ZedScan, a cervical diagnostic system developed by Zilico Ltd, is currently being adopted by healthcare systems across the globe and will be exhibited at MEDICA 2015.
Zilico Ltd will showcase ZedScan as an exhibitor on the Great Britain and Northern Ireland Pavilion(Hall 16 Stand G18-7).
Clinicians at a UK NHS clinic have been using ZedScan alongside colposcopy over a period of 18 months assessing the impact on the patient pathway for women referred with abnormal cytology.
Performance data on 1,052 women examined revealed a 12.4% increase in the detection of high grade cervical intraepithelial neoplasia (HG CIN) following the introduction of ZedScan into routine use.
The report concludes that adoption of ZedScan has created opportunities for more efficient use of resources by offering treatment at first visit as well as providing the reassurance to release women without disease to routine surveillance and reducing the need for further follow up.
ZedScan has been approved for use in a number of international markets including Canada, Australia, Bahrain and Israel, as well as a number of European countries.
If you would like to arrange an appointment with Zilico Ltd to discuss ZedScan during MEDICA, please firstname.lastname@example.org with your details and some information about your company.